fms-like tyrosine kinase
Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms like tyrosine kinase 1 levels: a nested case control study
... RESEARCH ARTICLE Open Access Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms like tyrosine kinase 1 levels a nested case control study Sus[.] ...
10
Effects of simvastatin, rosuvastatin and pravastatin on soluble fms like tyrosine kinase 1 (sFlt 1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta
... Effects of simvastatin, rosuvastatin and pravastatin on soluble fms like tyrosine kinase 1 (sFlt 1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophobla[.] ...
8
Survivin but not Fms like tyrosine kinase 3 ligand is up regulated before the onset of rheumatoid arthritis: a pilot study
... with Fms-like tyrosine kinase 3, its re- ceptor tyrosine ...kinase. Fms-like tyrosine kinase 3/Flt3L sig- naling has recently been shown critical for ...
7
Assessing the sensitivity of placental growth factor and soluble fms like tyrosine kinase 1 at 36 weeks’ gestation to predict small for gestational age infants or late onset preeclampsia: a prospective nested case control study
... soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), and the sFlt-1:PlGF ratio, measured at 36 weeks ’ gestation, in identifying women who subsequently give birth to ...
12
Excess Soluble fms-Like Tyrosine Kinase 1 and Low Platelet Counts in Premature Neonates of Preeclamptic Mothers
... To investigate the relation- ship of neonatal platelet count and preeclampsia to levels of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), and vascular endot[r] ...
7
Cytogenetic and FMS-Like Tyrosine Kinase 3 Mutation Analyses in Acute Promyelocytic Leukemia Patients
... receptor tyrosine kinases, which commonly accompany acute myelocytic leukemia (AML)-associated translocations including t(15;17), giving rise to the proposition that they could provide a common class of ...
8
Variability in mRNA expression of fms like tyrosine kinase 1 variants in normal and preeclamptic placenta
... proteinuria and is a leading cause of morbidity and mortality in both mothers and infants. Certain anti-angiogenic factors have long been implicated in the pathogenesis of preeclampsia and the placental expression of ...
5
Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy
... It was first proposed in 1997 that low levels of VEGF in maternal decidua may be a contributory factor in preeclampsia because of increased levels of endogenous sFlt-1, which may antagonize the beneficial effects of VEGF ...
16
Soluble Fms-like tyrosine kinase-1 alters cellular metabolism and mitochondrial bioenergetics in preeclampsia
... PE remains as the leading cause of maternal and neonatal deaths worldwide (Duley, 2009). Within the last decade, several reports opened a novel window for understanding the pathogenesis of the disease, by describing the ...
13
Intraperitoneal Injection of High Tumor Necrosis Factor (TNF-α) Serum Increase Soluble Fms-like Tyrosine Kinase-1 (sFlt-1) and Blood Pressure of Pregnant Mice
... The sFlt-1 is a vascular endothelial growth factor receptor 1 (VEGFR-1) or Flt-1 that lack of transmem- brane and a cytoplasmic domain. The sFlt-1 is not bind on the plasma membrane of the endothelial cell but soluble in ...
5
Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review
... There was no consistent pattern in association between sFlt-1 concentrations and fetal growth restriction (4 studies); and levels were non-significantly higher for women with postpartum [r] ...
8
Soluble fms like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia
... In normal pregnancy, despite enhanced Ang II and volume expansion, NO production is amplified (21, 43–47), likely by growth factors such as VEGF and placental growth factor that are required for normal placental ...
15
Vol 22, No 4 (2018)
... their tyrosine kinase receptors -1 and 2 (Flt-1 and KDR) are involved in both fetal and placental ...soluble fms-like tyrosine kinase 1 (sFlt-1) is thus instrumental in the ...
9
The Level of Soluble FMS Like Tyrosinkinase 1, Placental Growth Factor and Vitamin E in Pre Eclampsia and Normotensive Pregnancy
... (soluble FMS-like tyrosine kinase-1), Placental Growth Factor (PlGF) and antioxidant (vitamin E) levels in pre-eclampsia compared with normotensive ...
7
Clinical use of FLT3 inhibitors in acute myeloid leukemia
... Abstract: Acute myeloid leukemia (AML) is a highly heterogeneous disease. Mutation with internal tandem duplication of fms-like tyrosine kinase-3 (FLT3-ITD) is one of the two most common ...
12
HOX deregulation in acute myeloid leukemia
... Among the receptor tyrosine kinases RTKs, fms-like tyrosine kinase 3 FLT3, which plays important roles in hematopoietic progenitor cell survival and Nonstandard abbreviations used: AML, [r] ...
5
Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy
... The Fms-like tyrosine kinase-3 (FLT3; fetal liver kinase-2; human stem cell tyrosine kinase-1; CD135) is a class III receptor tyrosine kinase that is ...
8
Prospective observational study to evaluate the efficacy of Labetalol vs Nifedipine in management of pre-eclampsia. (Antepartum, Intrapartum)
... sFlt-1 soluble fms like tyrosine kinase is an anti-angiogenic factor is a potent inhibitor of VEGF and PIGF may play a causal role in the pathogenesis of pre-eclampsia and it is increase[r] ...
110
Economic assessment of the use of the sFlt 1/PlGF ratio test to predict preeclampsia in Germany
... Abstract Background: The PRediction of short-term Outcome in preGNant wOmen with Suspected preeclampsIa Study PROGNOSIS demonstrated that a soluble fms-like tyrosine kinase 1/placental g[r] ...
11
A high angiopoietin 2/angiopoietin 1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia
... Serum concentrations of soluble fms-like tyrosine kinase-1 sFlt-1, vascular endothelial growth factor-A VEGF-A and angiopoietin Ang -1 and Ang-2 in patients with non-complicated febrile [r] ...
10